Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Artocarpus altilis var. seedless
Seedless breadfruit cultivated in Puerto Rico and Caribbean for food and traditional medicine for hypertension and diabetes.
Puerto Rican Breadfruit (Artocarpus altilis var. seedless) is a seedless variety cultivated in the Caribbean, traditionally used as a nutritional staple and in folk medicine for hypertension and diabetes. Modern research suggests antihypertensive, antidiabetic, and anti-inflammatory properties, attributed to active compounds such as artocarpanone, cycloartenol, chlorogenic acid, and beta-sitosterol. Evidence is limited (Level C), primarily from pilot studies and traditional use.
Artocarpanone and chlorogenic acid may inhibit angiotensin-converting enzyme (ACE) and reduce oxidative stress, contributing to antihypertensive effects. Cycloartenol and beta-sitosterol are thought to modulate glucose metabolism by enhancing insulin sensitivity and promoting glucose uptake via AMPK activation. Anti-inflammatory actions are linked to suppression of NF-κB pathway and reduction of pro-inflammatory cytokines such as TNF-α and IL-6.
Seedless breadfruit cultivated in Puerto Rico and Caribbean for food and traditional medicine for hypertension and diabetes.
Puerto Rican Breadfruit (Artocarpus altilis var. seedless) is a seedless variety cultivated in the Caribbean, traditionally used as a nutritional staple and in folk medicine for hypertension and diabetes. Modern research suggests antihypertensive, antidiabetic, and anti-inflammatory properties, attributed to active compounds such as artocarpanone, cycloartenol, chlorogenic acid, and beta-sitosterol. Evidence is limited (Level C), primarily from pilot studies and traditional use.
Artocarpanone and chlorogenic acid may inhibit angiotensin-converting enzyme (ACE) and reduce oxidative stress, contributing to antihypertensive effects. Cycloartenol and beta-sitosterol are thought to modulate glucose metabolism by enhancing insulin sensitivity and promoting glucose uptake via AMPK activation. Anti-inflammatory actions are linked to suppression of NF-κB pathway and reduction of pro-inflammatory cytokines such as TNF-α and IL-6.